Lifespan extension therapy: Coenzyme Q10 may increase life span via up-regulation of its target gene BubR1, 12/January/2017, 12.39 am

Natural product-derived therapy for attenuating pathogenesis-associated with Myocardial infarction: A pharmaceutical mixture encompassing Sulforaphane, Myricitrin, and Aspalathin (SMA) decreases IRF3, GM-CSF (Granulocyte-macrophage colony-stimulating factor) and GRK2(G protein-coupled receptor kinase) expression, inhibits undue leucocyte activation and invasion, suppresses recruitment of inflmmatory cells, inhibits ventricular dilation, and promotes heart repair and survival via up regulation of its target gene, 11/January/2017, 11.48 pm
January 11, 2018
Molecular therapy for Metastatic cancers: Torasemide, an anti-hypertensive drug, increases the expression of tumor/metastatic suppressors RECK and CADM1, inhibits cell cycle progression, and suppresses migration, invasion and metastasis of cancer cells via up regulation of its target gene, 12/January/2017, 11.11 pm
January 12, 2018
Show all

 What they say: Introduction: 

A recent study from the Department of Genetics, Paul F. Glenn Laboratories for the Biological Mechanisms of Aging Harvard Medical School, Boston,USA; and Department of Pharmacology, School of Medicine, The University of New South Wales, Australia shows that Sirtuin-2 induces the checkpoint kinase BubR1 to increase lifespan. This study was published, in the 1 July  2014 issue of the journal  “EMBO”, by Prof Sinclair, North BJ, and others.

What we say: 

On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that:  Lifespan extension therapy: Coenzyme Q10 may increase life span via up-regulation of its target gene BubR1

What is known? 

Coenzyme Q10 has been shown to possess cardioprotective activity. However, the exact mechanism of action is far from clear.

From Research Findings to Therapeutic Opportunity: 

This study suggests, for the first time, that Coenzyme Q10by increasing the expression of its target gene, it may: (a) increase the expression of BuBR1; (b) decrease the expression of p70 S6 Kinase; and (c) regulate the expression of a number of longevity-promoting molecules (Fig. 1).

[easy_payment currency=”USD”]

Figure 1. Coenzyme Q10  may extend  mammalian life span via up regulation of BuBR1 and down regulation of p70 S6 Kinase

Figure 2. The chemical structure of Coenzyme Q10 .


Thereby, it may: (1) increase insulin sensitivity; (2) increase thermogenesis, lipolysis and oxidative metabolism; (3) inhibit obesity; (4) attenuate cognitive impairment; (5) delay diseases of aging; (6) slow down cardiac aging; (7) promote resistance to bone, immune and motor dysfunction; (8) promote tissue rejuvenation; and (9) prolong median life span. Thus, pharmacological formulations encompassing “Coenzyme Q10  or its analogues, either alone or in combination with other drugs may be used to extend the lifespan of an individual (fig. 1).

Details on the research findings: 

Idea Proposed/Formulated (with experimental evidence) by:

Dr L Boominathan Ph.D.

Amount: $500#

Undisclosed mechanistic information: How a pharmaceutical mix encompassing Coenzyme Q10 increases the expression of BubR1 and extends mammalian life-span

Terms & Conditions apply

# Research cooperation


Web: or

CitationBoominathan, L., Lifespan extension therapy: Coenzyme Q10 may increase life span via up-regulation of its target gene BubR1, 12/January/2017, 12.35 am,  Genome-2-Bio-Medicine Discovery center (GBMD),

Courtesy: When you cite drop us a line at

Comments are closed.